Your browser doesn't support javascript.
loading
Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment? / ¿Son los inhibidores del receptor SGLT2 fármacos antidiabéticos o cardiovasculares?
Vargas Delgado, Ariana P; Requena Ibañez, Juan Antonio; Santos-Gallego, Carlos G; Badimon, Juan Jose.
Afiliação
  • Vargas Delgado AP; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, Nueva York, EE. UU.
  • Requena Ibañez JA; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, Nueva York, EE. UU.. Electronic address: juan.antonio.requena.ib@gmail.com.
  • Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, Nueva York, EE. UU.
  • Badimon JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, Nueva York, EE. UU.
Clin Investig Arterioscler ; 2020 Oct 21.
Article em En, Es | MEDLINE | ID: mdl-34756346
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En / Es Revista: Clin Investig Arterioscler Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En / Es Revista: Clin Investig Arterioscler Ano de publicação: 2020 Tipo de documento: Article